0001213900-18-011211.txt : 20180815
0001213900-18-011211.hdr.sgml : 20180815
20180815170613
ACCESSION NUMBER: 0001213900-18-011211
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180813
FILED AS OF DATE: 20180815
DATE AS OF CHANGE: 20180815
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HOLUBIAK MYRON Z
CENTRAL INDEX KEY: 0001199080
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38174
FILM NUMBER: 181021654
MAIL ADDRESS:
STREET 1: C/O CITIUS PHARMACEUTICALS, INC.
STREET 2: 63 GREAT ROAD
CITY: MAYNARD
STATE: MA
ZIP: 01754
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Citius Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001506251
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 273425913
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 11 COMMERCE DRIVE
STREET 2: 1ST FLOOR
CITY: CRANFORD
STATE: NJ
ZIP: 07016
BUSINESS PHONE: (908) 967-6676
MAIL ADDRESS:
STREET 1: 11 COMMERCE DRIVE
STREET 2: 1ST FLOOR
CITY: CRANFORD
STATE: NJ
ZIP: 07016
FORMER COMPANY:
FORMER CONFORMED NAME: Trail One, Inc.
DATE OF NAME CHANGE: 20110314
FORMER COMPANY:
FORMER CONFORMED NAME: TrailOne, Inc.
DATE OF NAME CHANGE: 20101119
4
1
ownership.xml
X0306
4
2018-08-13
0
0001506251
Citius Pharmaceuticals, Inc.
CTXR
0001199080
HOLUBIAK MYRON Z
C/O CITIUS PHARMACEUTICALS, INC.
11 COMMERCE DRIVE, 1ST FLOOR
CRANFORD
NJ
07016
1
1
1
0
President and CEO
Common Stock
2018-08-13
4
P
0
784314
1.275
A
1304196
D
Warrant to Purchase Common Stock
1.15
2018-08-13
4
A
0
784314
A
2023-08-14
Common Stock
784314
784314
D
Options to Purchase Common Stock
8.10
2025-10-01
Common Stock
26667
26667
D
Options to Purchase Common Stock
3.45
2027-09-13
Common Stock
40000
40000
D
Warrant to Purchase Common Stock
6.21
2019-06-12
Common Stock
19615
19615
D
The warrant is fully vested and exercisable immediately.
The purchase price of the warrants was included in the purchase price of the common stock reported in Table I.
The option granted vested and became exercisable as follows: the option to purchase 2,667 shares of common stock of the Company (the "Common Stock") vested on October 1, 2015, and the balance of the option to purchase shares of Common Stock vested in twelve (12) equal installments commencing on December 31, 2015.
One-third of the shares of the Company's common stock underlying the grant vest on the first anniversary of the vesting commencement date, September 13, 2018. The remaining shares of the Company's common stock underlying the grant vest in equal monthly installments at the end of each month for two years following the initial vest.
/s/ Alexander M. Donaldson, by power of attorney
2018-08-15